首页 > 最新文献

Journal of Pharmaceutical Health Services Research最新文献

英文 中文
Assessment of prescribing patterns and medication errors related to prescriptions in hospitalized diabetes mellitus type-2 patients in Khyber Pakhtunkhwa, Pakistan 巴基斯坦开伯尔-普赫图赫瓦省2型糖尿病住院患者的处方模式和用药错误评估
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-09 DOI: 10.1093/jphsr/rmac057
Jamil ur Rahman, Tawseef Ahmad, Muhammad Khan, Asad Ur Rahman, Samia Ghani, F. Ullah Khan
Diabetes mellitus (DM type-2) is a common, non-transmittable disease that affects people all over the world. Polypharmacy and inappropriate prescribing are more common in diabetic individuals. One of the most critical and fundamental abilities a doctor requires is the ability to write prescriptions. In emerging countries like Pakistan, irrational drug prescribing is a major healthcare issue. This study aims to investigate the prescriptions errors in patients with DM type-2 prescriptions admitted in medical wards and outpatients’ visits departments at Khyber teaching hospital. In the Khyber Teaching Hospital in Peshawar, a prospective study was done to determine medicine prescribing patterns and identify prescription errors in hospitalized patients with DM type-2. Over the course of two months, 86 patients’ prescriptions were collected from the hospital’s medical ward. The pattern of prescriptions was investigated using WHO-recommended indicators, and prescription mistakes were identified. DM type-2 was shown to be substantially more common in females than in males in this clinical investigation. For the data analysis, various statistical methods were used and data were visualized. DM type-2 was more common in adults above the age of 65, according to age groups (51–60). It was revealed that the average number of medications per prescription was 8.37%. In this study, we discovered that patients with DM type-2 had higher rates of hypertension than those with other disorders. The percentage of prescriptions with generic names was 3.61%, antibiotics were 15.69%, and injectables were 47.22% of the total 720 medications prescribed. The dose strength was absent in 18.75% of the 720 medications, and 6.25% of the pharmaceuticals had an incorrect dosage form. To promote reasonable drug therapy, the prescription pattern and prescription errors have highlighted the necessity to build an accurate system of documenting and analysing therapy before issuing a prescription.
糖尿病(DM 2型)是一种常见的、不可传播的疾病,影响着世界各地的人们。多药治疗和不适当的处方在糖尿病患者中更为常见。医生需要的最关键和最基本的能力之一是开处方的能力。在像巴基斯坦这样的新兴国家,不合理的药物处方是一个主要的医疗问题。本研究旨在调查开伯尔教学医院内科病房和门诊部收治的2型糖尿病患者的处方错误。在白沙瓦的开伯尔教学医院,进行了一项前瞻性研究,以确定2型糖尿病住院患者的药物处方模式并确定处方错误。在两个月的时间里,从医院的医疗病房收集了86名患者的处方。使用世界卫生组织推荐的指标对处方模式进行调查,并确定处方错误。在这项临床研究中,2型糖尿病在女性中比在男性中更常见。对于数据分析,使用了各种统计方法,并将数据可视化。根据年龄组(51-60),2型糖尿病在65岁以上的成年人中更常见。结果显示,每个处方的平均药物数量为8.37%。在这项研究中,我们发现2型糖尿病患者的高血压发病率高于其他疾病患者。在处方的720种药物中,具有通用名称的处方比例为3.61%,抗生素为15.69%,注射剂为47.22%。在720种药物中,18.75%的药物没有剂量强度,6.25%的药物剂型不正确。为了促进合理的药物治疗,处方模式和处方错误突出了在开具处方之前建立准确的记录和分析治疗系统的必要性。
{"title":"Assessment of prescribing patterns and medication errors related to prescriptions in hospitalized diabetes mellitus type-2 patients in Khyber Pakhtunkhwa, Pakistan","authors":"Jamil ur Rahman, Tawseef Ahmad, Muhammad Khan, Asad Ur Rahman, Samia Ghani, F. Ullah Khan","doi":"10.1093/jphsr/rmac057","DOIUrl":"https://doi.org/10.1093/jphsr/rmac057","url":null,"abstract":"\u0000 \u0000 \u0000 Diabetes mellitus (DM type-2) is a common, non-transmittable disease that affects people all over the world. Polypharmacy and inappropriate prescribing are more common in diabetic individuals. One of the most critical and fundamental abilities a doctor requires is the ability to write prescriptions. In emerging countries like Pakistan, irrational drug prescribing is a major healthcare issue. This study aims to investigate the prescriptions errors in patients with DM type-2 prescriptions admitted in medical wards and outpatients’ visits departments at Khyber teaching hospital.\u0000 \u0000 \u0000 \u0000 In the Khyber Teaching Hospital in Peshawar, a prospective study was done to determine medicine prescribing patterns and identify prescription errors in hospitalized patients with DM type-2. Over the course of two months, 86 patients’ prescriptions were collected from the hospital’s medical ward. The pattern of prescriptions was investigated using WHO-recommended indicators, and prescription mistakes were identified. DM type-2 was shown to be substantially more common in females than in males in this clinical investigation. For the data analysis, various statistical methods were used and data were visualized.\u0000 \u0000 \u0000 \u0000 DM type-2 was more common in adults above the age of 65, according to age groups (51–60). It was revealed that the average number of medications per prescription was 8.37%. In this study, we discovered that patients with DM type-2 had higher rates of hypertension than those with other disorders. The percentage of prescriptions with generic names was 3.61%, antibiotics were 15.69%, and injectables were 47.22% of the total 720 medications prescribed. The dose strength was absent in 18.75% of the 720 medications, and 6.25% of the pharmaceuticals had an incorrect dosage form.\u0000 \u0000 \u0000 \u0000 To promote reasonable drug therapy, the prescription pattern and prescription errors have highlighted the necessity to build an accurate system of documenting and analysing therapy before issuing a prescription.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2023-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42803737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Japanese pharmacists’ information strategy using behavioural economics: provision of numerical information with ‘peak-end rule’ improves willingness to take a hypothetical medication 日本药剂师使用行为经济学的信息策略:提供具有“峰端规则”的数字信息提高了服用假设性药物的意愿
Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-01-06 DOI: 10.1093/jphsr/rmac056
Akira Yoshida, Norimitsu Horii, Shinji Oshima, Shigeru Oshima, Daisuke Kobayashi
Abstract Objectives Low medication adherence is considered a cause of exacerbated diseases and greater economic losses. Hence, information strategies that improve patients’ willingness to take medications have received considerable attention. Newer information strategies that utilise the ‘peak-end rule’ proposed in behavioural economics were investigated in this study to advance strategy development. Methods An online scenario survey was conducted among adults aged 20–79 years in Japan. One of four medication counselling videos on a hypothetical hypertension drug narrated by a pharmacist was viewed by the respondents and their willingness to take the medication was evaluated. The four scenarios differed according to the presence or absence of risk probability and the order in which risk and benefit were provided. Key findings The responses of 383 participants were analysed and the results revealed that providing risk probability increased their willingness to take medication (3%), whereas the estimated risk probability by the participants was 28.7% on an average when no numerical probability was provided. Moreover, when risk probability was provided in a benefit/risk order, the willingness to take medication increased than in the risk/benefit order. Conclusions The participants’ willingness to take medication improved when the pharmacists provided risk probability; this helped participants comprehend that the risk probability was lesser than their assumptions. Moreover, the participants’ attention to the numeric information in medication counselling can be elicited by the peak-end rule. The findings from the hypothetical scenarios employed in this study merit further testing in real-life situations for clinical application.
低药物依从性被认为是疾病加重和经济损失更大的原因。因此,提高患者服药意愿的信息策略受到了相当大的关注。本研究调查了利用行为经济学中提出的“峰端规则”的更新信息策略,以促进策略的发展。方法对日本20 ~ 79岁成人进行在线情景调查。受访者观看了四段由药剂师讲述的关于假设高血压药物的药物咨询视频中的一段,并评估了他们服用药物的意愿。根据风险概率的存在与否以及提供风险和收益的顺序,这四种情景有所不同。对383名参与者的回答进行了分析,结果显示,提供风险概率增加了他们服药的意愿(3%),而在没有提供数字概率的情况下,参与者估计的风险概率平均为28.7%。此外,当风险概率以利益/风险顺序提供时,服药意愿比以风险/利益顺序提供时增加。结论药师提供风险概率后,受试者服药意愿提高;这有助于参与者理解风险概率小于他们的假设。此外,在药物咨询中,参与者对数字信息的关注可以通过峰端规则引起。本研究中所采用的假设情景的结果值得在现实生活中进一步测试,以供临床应用。
{"title":"Japanese pharmacists’ information strategy using behavioural economics: provision of numerical information with ‘peak-end rule’ improves willingness to take a hypothetical medication","authors":"Akira Yoshida, Norimitsu Horii, Shinji Oshima, Shigeru Oshima, Daisuke Kobayashi","doi":"10.1093/jphsr/rmac056","DOIUrl":"https://doi.org/10.1093/jphsr/rmac056","url":null,"abstract":"Abstract Objectives Low medication adherence is considered a cause of exacerbated diseases and greater economic losses. Hence, information strategies that improve patients’ willingness to take medications have received considerable attention. Newer information strategies that utilise the ‘peak-end rule’ proposed in behavioural economics were investigated in this study to advance strategy development. Methods An online scenario survey was conducted among adults aged 20–79 years in Japan. One of four medication counselling videos on a hypothetical hypertension drug narrated by a pharmacist was viewed by the respondents and their willingness to take the medication was evaluated. The four scenarios differed according to the presence or absence of risk probability and the order in which risk and benefit were provided. Key findings The responses of 383 participants were analysed and the results revealed that providing risk probability increased their willingness to take medication (3%), whereas the estimated risk probability by the participants was 28.7% on an average when no numerical probability was provided. Moreover, when risk probability was provided in a benefit/risk order, the willingness to take medication increased than in the risk/benefit order. Conclusions The participants’ willingness to take medication improved when the pharmacists provided risk probability; this helped participants comprehend that the risk probability was lesser than their assumptions. Moreover, the participants’ attention to the numeric information in medication counselling can be elicited by the peak-end rule. The findings from the hypothetical scenarios employed in this study merit further testing in real-life situations for clinical application.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135276694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assorted Thoughts from the Retiring Editor 退休编辑的杂念
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-12-14 DOI: 10.1093/jphsr/rmac050
A. Wertheimer
{"title":"Assorted Thoughts from the Retiring Editor","authors":"A. Wertheimer","doi":"10.1093/jphsr/rmac050","DOIUrl":"https://doi.org/10.1093/jphsr/rmac050","url":null,"abstract":"","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47773029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation, cross-cultural adaptation and validation of the Health Belief Model Questionnaire (HBMQ) for weight management behaviour for use in a Southeast Asian country 用于东南亚国家体重管理行为的健康信念模型问卷(HBMQ)的翻译、跨文化适应和验证
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-12-12 DOI: 10.1093/jphsr/rmac052
Sivasankari Raman, S. C. Ong, G. Ooi
In the past 50 years, obesity and being overweight have become significant health concerns that cause a rise in the risk of illness, impairing quality of life and increasing financial burdens worldwide. The purpose of the study is to conduct translation and cross-cultural adaptation of a Health Belief Model Questionnaire (HBMQ) for weight management behaviour into the Malay language and to validate the questionnaire. The HBMQ was adapted and translated into the Malay language based on published international guidelines. The content validity and the face validity were analysed by a panel of 10 experts. A pilot test was conducted with 35 students from Universiti Sains Malaysia to evaluate internal consistency. A cross-sectional study was carried out by distributing the self-administered HBMQ to the general public in Malaysia and 505 subjects were successfully recruited. The construct validity was evaluated by exploratory factor analysis. The first 112 participants completed the survey again one week later for the evaluation of test-retest reliability. In total, 79 questions had an item-level content validity index (I-CVI) score of >0.80 and have been evaluated as excellent inferring acceptable content validity. The remaining seven items in the instrument had an I-CVI score < 0.80 and were removed based on the experts’ consensus. The item-level face validity index value for each item range was between 0.8 and 1.0, indicating a satisfactory level of face validity. For construct validity, eight factors were requested and 74 items had a significant to strong factor loading of >0.4. The rotation of items showed five items had factor loadings <0.4 (item numbers 14, 57, 77, 78 and 79) and have been removed. The findings in this study conclude that the translated Health Belief Model-Malay version has adequate content validity, face validity, construct validity and reliability.
在过去50年里,肥胖和超重已成为严重的健康问题,在世界范围内造成疾病风险上升、生活质量下降和经济负担增加。本研究的目的是将体重管理行为的健康信念模型问卷(HBMQ)翻译成马来语并进行跨文化改编,并验证问卷。HBMQ是根据已出版的国际指南改编并翻译成马来语的。内容效度和面孔效度由10名专家组成的小组进行分析。马来西亚圣士大学的35名学生进行了试点测试,以评估内部一致性。横断面研究通过向马来西亚公众分发自我管理的HBMQ进行,成功招募了505名受试者。采用探索性因子分析评价构念效度。第一批112名参与者在一周后再次完成调查,以评估重测信度。共有79个问题的项目级内容效度指数(I-CVI)得分为>.80,被评为优秀的推断可接受内容效度。仪器中其余7项I-CVI评分< 0.80,根据专家一致意见予以删除。项目层面的面效度指数值在0.8 ~ 1.0之间,显示出满意的面效度水平。在构念效度方面,共要求8个因子,其中74个因子的显著至强负荷为b>.4。项目轮换显示,有5个项目的因子负荷<0.4(项目编号14、57、77、78和79),已被删除。本研究发现马来语健康信念模型具有足够的内容效度、面孔效度、建构效度和信度。
{"title":"Translation, cross-cultural adaptation and validation of the Health Belief Model Questionnaire (HBMQ) for weight management behaviour for use in a Southeast Asian country","authors":"Sivasankari Raman, S. C. Ong, G. Ooi","doi":"10.1093/jphsr/rmac052","DOIUrl":"https://doi.org/10.1093/jphsr/rmac052","url":null,"abstract":"\u0000 \u0000 \u0000 In the past 50 years, obesity and being overweight have become significant health concerns that cause a rise in the risk of illness, impairing quality of life and increasing financial burdens worldwide. The purpose of the study is to conduct translation and cross-cultural adaptation of a Health Belief Model Questionnaire (HBMQ) for weight management behaviour into the Malay language and to validate the questionnaire.\u0000 \u0000 \u0000 \u0000 The HBMQ was adapted and translated into the Malay language based on published international guidelines. The content validity and the face validity were analysed by a panel of 10 experts. A pilot test was conducted with 35 students from Universiti Sains Malaysia to evaluate internal consistency. A cross-sectional study was carried out by distributing the self-administered HBMQ to the general public in Malaysia and 505 subjects were successfully recruited. The construct validity was evaluated by exploratory factor analysis. The first 112 participants completed the survey again one week later for the evaluation of test-retest reliability.\u0000 \u0000 \u0000 \u0000 In total, 79 questions had an item-level content validity index (I-CVI) score of >0.80 and have been evaluated as excellent inferring acceptable content validity. The remaining seven items in the instrument had an I-CVI score < 0.80 and were removed based on the experts’ consensus. The item-level face validity index value for each item range was between 0.8 and 1.0, indicating a satisfactory level of face validity. For construct validity, eight factors were requested and 74 items had a significant to strong factor loading of >0.4. The rotation of items showed five items had factor loadings <0.4 (item numbers 14, 57, 77, 78 and 79) and have been removed.\u0000 \u0000 \u0000 \u0000 The findings in this study conclude that the translated Health Belief Model-Malay version has adequate content validity, face validity, construct validity and reliability.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48263021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacovigilance practices in South Asian Association for Regional Cooperation countries: the need for collaboration 南亚区域合作联盟国家的药物警戒实践:合作的必要性
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-11-21 DOI: 10.1093/jphsr/rmac046
Muhammad Akhtar Abbas Khan, Saima Hamid, Z. Babar
One-fifth of the world’s population lives in eight countries that constitute the South Asian Association for Regional Cooperation (SAARC). There is very little coordination among SAARC countries regarding the harmonization of pharmaceutical regulations and medicines safety. Pakistan, India and Bangladesh have experienced medicine-related tragedies where many patients have died. This study aims to examine current pharmacovigilance activity in the SAARC region to improve pharmacovigilance practices and to make recommendations for building a platform for collaboration to improve the safety monitoring of medicines in the region. The current review utilized secondary data. We reviewed the official websites of all SAARC countries’ national regulatory authorities for pharmacovigilance-related information. A data set with eleven pharmacovigilance indicators were gathered and synthesized. All eight SAARC member countries have pharmacovigilance systems with full membership in the WHO Program for International Drug Monitoring. Out of eleven pharmacovigilance indicators, India met ten; Pakistan, Bangladesh and Bhutan nine; Maldives and Afghanistan seven; Nepal and Sri Lanka five. The SAARC countries do not have a harmonized pharmacovigilance system or centralized database. Due to positioning in different WHO regions, it is proposed to create a consortium on medicine safety among SAARC countries like other regional organizations of the world to strengthen the pharmacovigilance systems and harmonize the pharmacovigilance practices among member countries. To improve the quality of medicines and to strengthen regional medicine safety, the SAARC secretariat should consider forming a technical group of all member countries’ regulatory authorities.
世界人口的五分之一生活在南亚区域合作联盟(南盟)的八个国家。南盟国家之间在统一药品条例和药品安全方面几乎没有进行协调。巴基斯坦、印度和孟加拉国都经历了与药物有关的悲剧,许多患者死亡。本研究旨在检查南盟地区目前的药物警戒活动,以改进药物警戒实践,并为建立合作平台以改进该地区药物的安全监测提出建议。目前的审查利用了次要数据。我们查阅了所有南盟国家监管机构的官方网站,了解药物警戒相关信息。收集并合成了包含11个药物警戒指标的数据集。南盟所有八个成员国都有药物警戒系统,并成为世界卫生组织国际药物监测方案的正式成员。在11项药物警戒指标中,印度达到了10项;巴基斯坦、孟加拉国和不丹9个;马尔代夫和阿富汗7个;尼泊尔和斯里兰卡五个。南盟国家没有统一的药物警戒系统或中央数据库。由于定位在不同的世界卫生组织区域,建议像世界其他区域组织一样,在南盟国家之间建立一个药物安全联盟,以加强药物警戒系统,协调成员国之间的药物警戒实践。为了提高药品质量和加强区域药品安全,南盟秘书处应考虑成立一个由所有成员国监管机构组成的技术小组。
{"title":"Pharmacovigilance practices in South Asian Association for Regional Cooperation countries: the need for collaboration","authors":"Muhammad Akhtar Abbas Khan, Saima Hamid, Z. Babar","doi":"10.1093/jphsr/rmac046","DOIUrl":"https://doi.org/10.1093/jphsr/rmac046","url":null,"abstract":"\u0000 \u0000 \u0000 One-fifth of the world’s population lives in eight countries that constitute the South Asian Association for Regional Cooperation (SAARC). There is very little coordination among SAARC countries regarding the harmonization of pharmaceutical regulations and medicines safety. Pakistan, India and Bangladesh have experienced medicine-related tragedies where many patients have died. This study aims to examine current pharmacovigilance activity in the SAARC region to improve pharmacovigilance practices and to make recommendations for building a platform for collaboration to improve the safety monitoring of medicines in the region.\u0000 The current review utilized secondary data. We reviewed the official websites of all SAARC countries’ national regulatory authorities for pharmacovigilance-related information. A data set with eleven pharmacovigilance indicators were gathered and synthesized.\u0000 \u0000 \u0000 \u0000 All eight SAARC member countries have pharmacovigilance systems with full membership in the WHO Program for International Drug Monitoring. Out of eleven pharmacovigilance indicators, India met ten; Pakistan, Bangladesh and Bhutan nine; Maldives and Afghanistan seven; Nepal and Sri Lanka five. The SAARC countries do not have a harmonized pharmacovigilance system or centralized database. Due to positioning in different WHO regions, it is proposed to create a consortium on medicine safety among SAARC countries like other regional organizations of the world to strengthen the pharmacovigilance systems and harmonize the pharmacovigilance practices among member countries.\u0000 \u0000 \u0000 \u0000 To improve the quality of medicines and to strengthen regional medicine safety, the SAARC secretariat should consider forming a technical group of all member countries’ regulatory authorities.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48675101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of drug use pattern in adults’ outpatient clinics in a tertiary teaching hospital using WHO core prescribing indicators 应用世卫组织核心处方指标评价某三级教学医院成人门诊用药模式
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-11-16 DOI: 10.1093/jphsr/rmac048
R. A. Abu Farha, O. Awwad, B. Abdurazaq, K. Abu Hammour, A. Akour
This study has evaluated the drug use pattern among adults attending the outpatient clinics of the Jordan University Hospital (JUH), by assessing the adherence of prescriptions to the World Health Organization (WHO) core prescribing indicators. This is a cross-sectional study that was conducted during the period from October 2011 to January 2022 at JUH. Several prescriptions from 10 different adult outpatient clinics were reviewed to evaluate hospital adherence to the five WHO core prescribing indicators. To assess the WHO core prescribing indicators, data for 2451 prescriptions were reviewed. Around one-third of the patients (33.4%) were receiving polypharmacy (five medications or more). Results revealed that two core prescribing indicators were not following the standard values specified by the WHO; the average number of drugs prescribed per encounter (3.8 medications/prescription), and the percentage of drugs from the essential drug list (EDL) (54.1%). Endocrine clinics showed the highest average of drugs (6.3) per prescription and the highest percentage of prescriptions with injectable medicines (51.7%). On the other hand, ophthalmology clinics showed the highest percentage of prescriptions with antibiotics (29.9%) and the lowest percentage of drugs prescribed from the EDL at JUH (14.1%). Evaluating factors affecting the number of prescribed medications per encounter revealed that elderly patients (> 60 years), being female, referring to the endocrine clinic, and having insurance have a higher average number of medications per encounter compared with others (P < 0.05). The proper prescribing practices in a sizable tertiary hospital in Amman, Jordan, are clarified by this study. The percentage of medications from EDL and the typical number of drugs/encounters did not comply with WHO requirements. The study findings should guide the Jordanian health policymakers in designing and implementing strategies to limit irrational prescribing practices and raise awareness of and ensure physician adherence to the national EDL.
本研究通过评估处方对世界卫生组织(世界卫生组织)核心处方指标的遵守情况,评估了在约旦大学医院(JUH)门诊就诊的成年人的药物使用模式。这是2011年10月至2022年1月在JUH进行的一项横断面研究。对10个不同成人门诊的几张处方进行了审查,以评估医院对世界卫生组织五项核心处方指标的遵守情况。为了评估世界卫生组织的核心处方指标,审查了2451个处方的数据。大约三分之一的患者(33.4%)正在接受多种药物治疗(五种或五种以上药物)。结果显示,有两项核心处方指标未达到世界卫生组织规定的标准值;平均每次处方的药物数量(3.8种药物/处方),以及基本药物清单(EDL)中药物的百分比(54.1%)。内分泌诊所显示,每次处方的平均药物数量最高(6.3种),注射药物处方的百分比最高(51.7%)。另一方面,眼科诊所显示,在JUH,使用抗生素的处方比例最高(29.9%),EDL开出的药物比例最低(14.1%)。影响每次就诊处方药物数量的评估因素显示,老年患者(>60岁)(女性)在内分泌诊所就诊时,与其他人相比,有保险的人每次就诊的平均药物数量更高(P<0.05)。本研究阐明了约旦安曼一家大型三级医院的正确处方做法。EDL的药物百分比和药物/接触的典型数量不符合世界卫生组织的要求。研究结果应指导约旦卫生政策制定者设计和实施策略,以限制不合理的处方做法,提高对国家EDL的认识并确保医生遵守国家EDL。
{"title":"Evaluation of drug use pattern in adults’ outpatient clinics in a tertiary teaching hospital using WHO core prescribing indicators","authors":"R. A. Abu Farha, O. Awwad, B. Abdurazaq, K. Abu Hammour, A. Akour","doi":"10.1093/jphsr/rmac048","DOIUrl":"https://doi.org/10.1093/jphsr/rmac048","url":null,"abstract":"\u0000 \u0000 \u0000 This study has evaluated the drug use pattern among adults attending the outpatient clinics of the Jordan University Hospital (JUH), by assessing the adherence of prescriptions to the World Health Organization (WHO) core prescribing indicators.\u0000 \u0000 \u0000 \u0000 This is a cross-sectional study that was conducted during the period from October 2011 to January 2022 at JUH. Several prescriptions from 10 different adult outpatient clinics were reviewed to evaluate hospital adherence to the five WHO core prescribing indicators.\u0000 \u0000 \u0000 \u0000 To assess the WHO core prescribing indicators, data for 2451 prescriptions were reviewed. Around one-third of the patients (33.4%) were receiving polypharmacy (five medications or more). Results revealed that two core prescribing indicators were not following the standard values specified by the WHO; the average number of drugs prescribed per encounter (3.8 medications/prescription), and the percentage of drugs from the essential drug list (EDL) (54.1%). Endocrine clinics showed the highest average of drugs (6.3) per prescription and the highest percentage of prescriptions with injectable medicines (51.7%). On the other hand, ophthalmology clinics showed the highest percentage of prescriptions with antibiotics (29.9%) and the lowest percentage of drugs prescribed from the EDL at JUH (14.1%). Evaluating factors affecting the number of prescribed medications per encounter revealed that elderly patients (> 60 years), being female, referring to the endocrine clinic, and having insurance have a higher average number of medications per encounter compared with others (P < 0.05).\u0000 \u0000 \u0000 \u0000 The proper prescribing practices in a sizable tertiary hospital in Amman, Jordan, are clarified by this study. The percentage of medications from EDL and the typical number of drugs/encounters did not comply with WHO requirements. The study findings should guide the Jordanian health policymakers in designing and implementing strategies to limit irrational prescribing practices and raise awareness of and ensure physician adherence to the national EDL.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44006084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Researchers’ experiences of pharmacy involvement: a UK cross-sectional survey 研究人员参与药学的经历:一项英国横断面调查
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-11-16 DOI: 10.1093/jphsr/rmac049
Michelle Watson, C. Whittlesea, P. Tharmanathan
We aimed to explore the experiences and opinions of researchers who have involved pharmacy professionals in research studies. Pharmacy teams are valued healthcare professionals, with a wide knowledge base and skill set. They have regular contact with service users who may be interested in research, placing them in a good position for collaboration with researchers. Cross-sectional survey circulated to researchers in the UK; analysed using descriptive, quantitative methods. A total of 238 responses were received from researchers, mainly within hospitals and universities. Most had more than 10 years of experience (45%) and had worked on 2–10 studies involving pharmacies (54%), frequently requiring hospital services (74%). Two-thirds of researchers had worked on clinical trials of investigational medicinal products. Most researchers worked with pharmacy teams that all had previous research experience (78%) yet did not involve them in participant recruitment (85%). Pharmacy staff frequently managed or dispensed medication (43%), however also engaged with other research-related tasks. Their previous experience and keenness were desirable qualities for researchers. Many respondents had a positive experience of collaboration and acknowledged various advantages (e.g. developing training/knowledge) and disadvantages (e.g. staffing issues). Researchers’ positive impression of working with the pharmacy sector bodes well for future collaborations. Many had experience with pharmacy, however, those more unfamiliar should consider the roles staff could perform; and pharmacy teams and professional bodies should advocate their involvement. For collaboration to prosper, we should promote the benefits of research engagement and consider how to overcome known challenges.
我们旨在探讨让药学专业人员参与研究的研究人员的经验和意见。药房团队是有价值的医疗保健专业人员,拥有广泛的知识基础和技能。他们定期与可能对研究感兴趣的服务用户联系,这使他们处于与研究人员合作的有利地位。向英国研究人员分发的横断面调查;使用描述性、定量方法进行分析。研究人员共收到238份回复,主要来自医院和大学。大多数人有超过10年的工作经验(45%),参与过2-10项涉及药房的研究(54%),经常需要医院服务(74%)。三分之二的研究人员从事过试验药物的临床试验。大多数研究人员与药房团队合作,这些团队都有过研究经验(78%),但没有参与参与者招募(85%)。药房工作人员经常管理或分配药物(43%),但也从事其他研究相关任务。他们以前的经验和敏锐是研究人员所期望的品质。许多受访者有积极的合作经验,并承认各种优势(如发展培训/知识)和劣势(如人员配置问题)。研究人员对与制药行业合作的积极印象预示着未来的合作。许多人都有药房的经验,然而,那些更不熟悉的人应该考虑员工可以扮演的角色;药房团队和专业机构应倡导他们的参与。为了促进合作,我们应该促进研究参与的好处,并考虑如何克服已知的挑战。
{"title":"Researchers’ experiences of pharmacy involvement: a UK cross-sectional survey","authors":"Michelle Watson, C. Whittlesea, P. Tharmanathan","doi":"10.1093/jphsr/rmac049","DOIUrl":"https://doi.org/10.1093/jphsr/rmac049","url":null,"abstract":"\u0000 \u0000 \u0000 We aimed to explore the experiences and opinions of researchers who have involved pharmacy professionals in research studies. Pharmacy teams are valued healthcare professionals, with a wide knowledge base and skill set. They have regular contact with service users who may be interested in research, placing them in a good position for collaboration with researchers.\u0000 \u0000 \u0000 \u0000 Cross-sectional survey circulated to researchers in the UK; analysed using descriptive, quantitative methods.\u0000 \u0000 \u0000 \u0000 A total of 238 responses were received from researchers, mainly within hospitals and universities. Most had more than 10 years of experience (45%) and had worked on 2–10 studies involving pharmacies (54%), frequently requiring hospital services (74%). Two-thirds of researchers had worked on clinical trials of investigational medicinal products. Most researchers worked with pharmacy teams that all had previous research experience (78%) yet did not involve them in participant recruitment (85%). Pharmacy staff frequently managed or dispensed medication (43%), however also engaged with other research-related tasks. Their previous experience and keenness were desirable qualities for researchers. Many respondents had a positive experience of collaboration and acknowledged various advantages (e.g. developing training/knowledge) and disadvantages (e.g. staffing issues).\u0000 \u0000 \u0000 \u0000 Researchers’ positive impression of working with the pharmacy sector bodes well for future collaborations. Many had experience with pharmacy, however, those more unfamiliar should consider the roles staff could perform; and pharmacy teams and professional bodies should advocate their involvement. For collaboration to prosper, we should promote the benefits of research engagement and consider how to overcome known challenges.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46559682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context 13价肺炎球菌结合疫苗与10价疫苗在儿童中的成本效益比较:厄瓜多尔背景下的预测分析
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-10-18 DOI: 10.1093/jphsr/rmac040
R. Bolaños-Díaz, Greta Miño-León, E. Zea
To evaluate the cost-effectiveness and economic impact of changing childhood vaccination from the 10-valent pneumococcal conjugate vaccine (PCV10) to the 13-valent pneumococcal conjugate vaccine (PCV13) in the context of the Ecuadorian health system. A Markov model was developed based on a hypothetical cohort of children <1 year old with a 2 + 1 vaccination schedule. The model incorporates the most impactful chronic sequelae of invasive pneumococcal disease: bilateral hearing loss, spasticity, neurological deficit, hydrocephalus and epilepsy. At the end of each annual Markov cycle, the children heal with/without sequelae or die. A time horizon of 5 years was considered. The analysis was done from the perspective of the Ministry of Health. Vaccination with PCV13 is cost-saving (US$ −2940/QALY) in relation to PCV10 considering indirect effects (‘herd effect’) of childhood vaccination over adult population (>65 years). So, PCV13 reduces incident cases of IPD in this adult population by 27.8% compared to PCV10. Simulation of the model in a cohort of 100 000 children <1 year old showed an incidence of 25 cases of IPD with PCV13 versus 40 cases with PCV10, that is, a reduction of 37.5%. A reduction compared to PCV10 in the incidence of pneumonia and meningitis of 30.2 and 57.1%, respectively, was demonstrated. PCV13 decreased mortality by 32% compared to PCV10. Vaccination with PCV13 is cost-saving in the Ecuadorian health context and significantly reduces morbidity and mortality in children <5 years and in adults >65 years due to the herd effect. The probabilistic analysis showed consistency in the results.
在厄瓜多尔卫生系统的背景下,评估将儿童疫苗接种从10价肺炎球菌结合疫苗(PCV10)改为13价肺炎球菌结合疫苗(PCV13)的成本效益和经济影响。一个马尔可夫模型是基于一个假设的65岁儿童队列建立的。因此,与PCV10相比,PCV13在成年人群中减少了27.8%的IPD病例。由于群体效应,该模型在10万名65岁儿童队列中进行了模拟。概率分析显示了结果的一致性。
{"title":"Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine compared to the 10-valent vaccine in children: predictive analysis in the Ecuadorian context","authors":"R. Bolaños-Díaz, Greta Miño-León, E. Zea","doi":"10.1093/jphsr/rmac040","DOIUrl":"https://doi.org/10.1093/jphsr/rmac040","url":null,"abstract":"\u0000 \u0000 \u0000 To evaluate the cost-effectiveness and economic impact of changing childhood vaccination from the 10-valent pneumococcal conjugate vaccine (PCV10) to the 13-valent pneumococcal conjugate vaccine (PCV13) in the context of the Ecuadorian health system.\u0000 \u0000 \u0000 \u0000 A Markov model was developed based on a hypothetical cohort of children <1 year old with a 2 + 1 vaccination schedule. The model incorporates the most impactful chronic sequelae of invasive pneumococcal disease: bilateral hearing loss, spasticity, neurological deficit, hydrocephalus and epilepsy. At the end of each annual Markov cycle, the children heal with/without sequelae or die. A time horizon of 5 years was considered. The analysis was done from the perspective of the Ministry of Health.\u0000 \u0000 \u0000 \u0000 Vaccination with PCV13 is cost-saving (US$ −2940/QALY) in relation to PCV10 considering indirect effects (‘herd effect’) of childhood vaccination over adult population (>65 years). So, PCV13 reduces incident cases of IPD in this adult population by 27.8% compared to PCV10. Simulation of the model in a cohort of 100 000 children <1 year old showed an incidence of 25 cases of IPD with PCV13 versus 40 cases with PCV10, that is, a reduction of 37.5%. A reduction compared to PCV10 in the incidence of pneumonia and meningitis of 30.2 and 57.1%, respectively, was demonstrated. PCV13 decreased mortality by 32% compared to PCV10.\u0000 \u0000 \u0000 \u0000 Vaccination with PCV13 is cost-saving in the Ecuadorian health context and significantly reduces morbidity and mortality in children <5 years and in adults >65 years due to the herd effect. The probabilistic analysis showed consistency in the results.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46788619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of measurement invariance of psychometric tool for pharmaceutical sales executives: implications for social and behavioural pharmacy research 医药销售人员心理测量工具测量不变性的评估:对社会与行为药学研究的启示
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-10-14 DOI: 10.1093/jphsr/rmac041
T. Oamen, J. Idiake, Oamen Sophia Omorenuwa
To assess the measurement invariance quality of a short-item employee work assessment questionnaire across key subgroups of pharmaceutical executives. A cross-sectional study with data collected using a nine-item structured questionnaire randomly administered to 406 pharmaceutical executives in Nigeria. Structural equation modelling using Analysis of Moment Structures (AMOS) version 24, and criteria for invariance were absolute change in goodness-of-fit criteria and chi-square test at P < 0.05. Results showed gender [men (n = 293, 72%), women (n = 113, 28%)], [pharmacist (n = 117, 28.8%, non-pharmacist (n = 289, 71.2%)], company type [indigenous (n = 249, 61%), multinational (n = 157, 39%)], and industry experience [low experience; ≤10 years (n = 363, 89%), high experience: ≥10 years (n = 43, 11%)]. Model-fit and construct validity of the instrument were satisfactory. Configural, metric, scalar, and residual invariance of the instrument were confirmed across gender, professional training, and experience levels. Only configural and metric invariance were attained for company type. The developed questionnaire is adequate for assessing pharmacy workforce perception across multiple demographic groups. Invariance testing and reporting are beneficial in social, administrative, and behavioural pharmacy research.
评估一份短项目员工工作评估问卷的测量不变性质量。一项横断面研究,数据收集使用九项结构化问卷随机管理406制药高管在尼日利亚。结构方程建模采用Analysis of Moment Structures (AMOS)第24版,不变性标准为拟合优度标准的绝对变化和卡方检验,P < 0.05。结果显示性别[男性(n = 293, 72%),女性(n = 113, 28%)],[药剂师(n = 117, 28.8%,非药剂师(n = 289, 71.2%)],公司类型[本土(n = 249, 61%),跨国公司(n = 157, 39%)],行业经验[低经验;≤10年(n = 363, 89%),高经验:≥10年(n = 43, 11%)。该工具的模型拟合和结构效度令人满意。仪器的构型、度量、标量和剩余不变性在性别、专业培训和经验水平之间得到确认。对于公司类型,仅获得了配置和度量不变性。开发的问卷足以评估跨多个人口统计群体的药房工作人员的看法。不变性检验和报告在社会、行政和行为药学研究中是有益的。
{"title":"Assessment of measurement invariance of psychometric tool for pharmaceutical sales executives: implications for social and behavioural pharmacy research","authors":"T. Oamen, J. Idiake, Oamen Sophia Omorenuwa","doi":"10.1093/jphsr/rmac041","DOIUrl":"https://doi.org/10.1093/jphsr/rmac041","url":null,"abstract":"\u0000 \u0000 \u0000 To assess the measurement invariance quality of a short-item employee work assessment questionnaire across key subgroups of pharmaceutical executives.\u0000 \u0000 \u0000 \u0000 A cross-sectional study with data collected using a nine-item structured questionnaire randomly administered to 406 pharmaceutical executives in Nigeria. Structural equation modelling using Analysis of Moment Structures (AMOS) version 24, and criteria for invariance were absolute change in goodness-of-fit criteria and chi-square test at P < 0.05.\u0000 \u0000 \u0000 \u0000 Results showed gender [men (n = 293, 72%), women (n = 113, 28%)], [pharmacist (n = 117, 28.8%, non-pharmacist (n = 289, 71.2%)], company type [indigenous (n = 249, 61%), multinational (n = 157, 39%)], and industry experience [low experience; ≤10 years (n = 363, 89%), high experience: ≥10 years (n = 43, 11%)]. Model-fit and construct validity of the instrument were satisfactory. Configural, metric, scalar, and residual invariance of the instrument were confirmed across gender, professional training, and experience levels. Only configural and metric invariance were attained for company type.\u0000 \u0000 \u0000 \u0000 The developed questionnaire is adequate for assessing pharmacy workforce perception across multiple demographic groups. Invariance testing and reporting are beneficial in social, administrative, and behavioural pharmacy research.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47085620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The use of complementary and alternative medicine in fertility and gynaecological disorders in Jordan: a mixed-method descriptive study 在约旦生育和妇科疾病中使用补充和替代医学:一项混合方法描述性研究
IF 0.7 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-10-14 DOI: 10.1093/jphsr/rmac039
Rana Al-Nimri, A. Akour, V. Kasabri, A. Al-Samydai
The aim of the study is to assess the extent of CAM use, with emphasis on herbs, in treating gynecological disorders, and their perceived efficacy and safety. This was a mixed-method study of two parts (cross-sectional quantitative and qualitative study) of 338 women suffering from gynecological disorders during the last 3 months. Data were collected using a self-administered questionnaire of three parts: demographics, medical history and the CAM use patterns. Qualitative part was conducted by a 20-min verbal face-to-face interview. During the last 3 months, 232 (68.64%) of participants had used CAM for various gynaecological conditions, of which, 135 (58.19%) used herbal remedies. Almost half of participants have a good awareness about CAM definition, and they mainly used CAM before or concurrently with traditional medicines. This study provides an overview of various CAM remedies used to treat gynaecological disorders in the Jordanian society, which would draw attention to the necessity of conducting interventional studies to evaluate the efficacy and safety of CAM in treating gynaecological disorders, either as stand-alone or adjuvant treatment.
该研究的目的是评估CAM的使用程度,重点是草药治疗妇科疾病,以及它们的疗效和安全性。本研究采用两部分混合方法(横断面定量研究和定性研究),对338名近3个月患有妇科疾病的妇女进行研究。数据收集使用自我管理的三部分问卷:人口统计,病史和CAM使用模式。定性部分通过20分钟的口头面对面访谈进行。在过去3个月中,232名(68.64%)参与者使用CAM治疗各种妇科疾病,其中135名(58.19%)使用草药治疗。几乎一半的参与者对CAM的定义有很好的认识,他们主要在使用传统药物之前或同时使用CAM。这项研究概述了约旦社会中用于治疗妇科疾病的各种辅助辅助治疗方法,这将引起人们对开展干预性研究的必要性的关注,以评估辅助辅助治疗妇科疾病的有效性和安全性,无论是作为单独治疗还是辅助治疗。
{"title":"The use of complementary and alternative medicine in fertility and gynaecological disorders in Jordan: a mixed-method descriptive study","authors":"Rana Al-Nimri, A. Akour, V. Kasabri, A. Al-Samydai","doi":"10.1093/jphsr/rmac039","DOIUrl":"https://doi.org/10.1093/jphsr/rmac039","url":null,"abstract":"\u0000 \u0000 \u0000 The aim of the study is to assess the extent of CAM use, with emphasis on herbs, in treating gynecological disorders, and their perceived efficacy and safety.\u0000 \u0000 \u0000 \u0000 This was a mixed-method study of two parts (cross-sectional quantitative and qualitative study) of 338 women suffering from gynecological disorders during the last 3 months. Data were collected using a self-administered questionnaire of three parts: demographics, medical history and the CAM use patterns. Qualitative part was conducted by a 20-min verbal face-to-face interview.\u0000 \u0000 \u0000 \u0000 During the last 3 months, 232 (68.64%) of participants had used CAM for various gynaecological conditions, of which, 135 (58.19%) used herbal remedies. Almost half of participants have a good awareness about CAM definition, and they mainly used CAM before or concurrently with traditional medicines.\u0000 \u0000 \u0000 \u0000 This study provides an overview of various CAM remedies used to treat gynaecological disorders in the Jordanian society, which would draw attention to the necessity of conducting interventional studies to evaluate the efficacy and safety of CAM in treating gynaecological disorders, either as stand-alone or adjuvant treatment.\u0000","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" ","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43683335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pharmaceutical Health Services Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1